Cytomegalovirus Disease Unknown Status Phase 2 Trials for Valganciclovir (DB01610)

Back to Cytomegalovirus Disease

Also known as: Cytomegaloviral disease, unspecified / Cytomegalovirus Infections / Cytomegalovirus infection / Cytomegalovirus infection (disorder) / Cytomegalic inclusion disease / Cytomegaloviral disease / CMV infection / Cytomegaloviral infections

Indication	Status	Phase
DBCOND0042800 (Cytomegalovirus Disease)	Unknown Status	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00828503	Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients	Treatment	Everolimus (DB01590) Valganciclovir (DB01610)